血管炎领域的新兴细胞疗法
Meghan E Free1,2,3
1Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Rheumatology (Oxford, England)
|March 12, 2025
概括
针对ANCA血管炎的新疗法旨在向特定的抗原和免疫细胞,超越广泛的免疫抑制. 这种方法旨在提高治疗效率,同时降低ANCA相关血管炎患者的感染风险.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 自免疫性疾病 自免疫性疾病
背景情况:
- ANCA血管炎是一种小血管血管炎,由MPO或PR3的自身抗体驱动.
- 目前的广谱免疫抑制是有效的,但会增加感染易感性.
- 了解疾病的发病因子,包括自身抗原的特异性和免疫细胞的作用,已经进步.
研究的目的:
- 审查ANCA血管炎中新型抗原和细胞特异性疗法的当前研究环境.
- 探索超越传统免疫抑制的新兴治疗策略.
主要方法:
- 关于ANCA血管炎病原和治疗方法的当前科学文献的综述.
- 分析针对特定免疫成分的潜在新疗法.
主要成果:
- 研究已经确定了关键的自身抗原 (MPO,PR3) 和参与ANCA血管炎的免疫细胞子集.
- 一些有前途的细胞特异性治疗途径正在出现,包括双特异性抗体,宽容性脂质体和工程T细胞.
- 恢复调节性T细胞功能是长期缓解的潜在策略.
结论:
- 该领域正在向针对ANCA血管炎的更有针对性的治疗方法迈进.
- 新兴的基于细胞的疗法有可能提高疗效和减少副作用.
- 对这些新的方法进行进一步的研究是有必要的.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Mechanism of Angiogenesis
5.2K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.2K
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457


